{
    "code": "02023755",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023755",
    "time": "2016-07-08 03:10:11",
    "許可證字號": "衛署藥輸字第023755號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/06\/20",
    "發證日期": "92\/06\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202375508",
    "中文品名": "輔舒酮 優氟 吸入劑５０微公克／劑量",
    "英文品名": "FLIXOTIDE EVOHALER 50MCG",
    "適應症": "用於預防性治療成人及兒童氣喘。",
    "劑型": "103口腔吸入劑",
    "包裝": "50MCG\/DOSE,金屬罐裝附吸入器 60、120劑量金屬罐裝附吸入器",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "FLUTICASONE PROPIONATE MICRONIZED",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1115901100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": {
        "製造廠名稱": "F410122000  GLAXO WELLCOME, S.A.",
        "製造廠廠址": "AVENIDA EXTREMADURA 3 09400 ARANDA DE DUERO BURGOS SPAIN",
        "製造廠公司地址": "",
        "製造廠國別": "SPAIN",
        "製程": ""
    },
    "CCC號列": "30043200002 含有腎上腺皮質類固醇荷爾蒙，其衍生物及結構式類似者Containing adrenal corticosteroid hormones, their derivatives and structural analogues",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F020037000  GLAXOSMITHKLINE AUSTRALIA PTY LTD",
            "製造廠廠址": "1061 MOUNTAIN HIGHWAY, BORONIA, VICTORIA 3155,AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8406002220",
            "成分名稱": "FLUTICASONE PROPIONATE MICRONIZED",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MCG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "4.6cm x 7.7cm",
        "特殊劑型": "",
        "顏色": "橘粉色吸入器及金屬罐",
        "特殊氣味": "",
        "刻痕": "0",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020237550003-104-09-24.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=003&Type=10"
        },
        {
            "title": "020237550002-104-09-24.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=002&Type=10"
        },
        {
            "title": "020237550001-104-09-24.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "02023755-105-06-06.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=004&Type=9"
        },
        {
            "title": "Flixotide Evo 50 L814-605-02_10000000130596-104-09-03.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=003&Type=9"
        },
        {
            "title": "020237550002-103-05-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=002&Type=9"
        },
        {
            "title": "020237550001-103-05-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=001&Type=9"
        },
        {
            "title": "Flioxtide Evo 50 M814-605-02_10000000123613-104-09-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023755&Seq=001&Type=8"
        }
    ]
}